Literature DB >> 15055464

Adrenal dysregulation in amyotrophic lateral sclerosis.

F R Patacchioli1, P Monnazzi, A Scontrini, E Tremante, I Caridi, E Brunetti, F R Buttarelli, F E Pontieri.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a chronic progressive neuromuscular disorder of unknown etiology, characterized by weakness, muscle wasting, fasciculations and increased reflexes, with conserved intellect and higher function. The disease is due to degeneration of the motor neurons in the cerebral cortex, brainstem nuclei and anterior horns of the spinal cord. Although ALS poses an extreme burden on individual condition, data are missing concerning the regulation of adrenal function in the disease. In the present study we investigated cortisol levels in saliva of ALS patients as compared to healthy subjects. The results showed the loss of circadian rhythm of cortisol levels in ALS; in particular, levels of cortisol in the evening sample were significantly increased in ALS patients with respect to controls. Moreover, ALS patients did not show any physiological increase of cortisol levels following an unexpected mild stress (color-word Stroop test). These findings indicate the dysregulation of adrenal activity in the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15055464     DOI: 10.1007/BF03349149

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS-resistant brain stem motor cell groups.

Authors:  L Medina; G Figueredo-Cardenas; J D Rothstein; A Reiner
Journal:  Exp Neurol       Date:  1996-12       Impact factor: 5.330

Review 3.  Oxidative stress in neurodegenerative diseases.

Authors:  N A Simonian; J T Coyle
Journal:  Annu Rev Pharmacol Toxicol       Date:  1996       Impact factor: 13.820

4.  Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS).

Authors:  F R Patacchioli; L Angelucci; G Dellerba; P Monnazzi; O Leri
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

Review 5.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

6.  Response variability of salivary cortisol under psychological stimulation.

Authors:  C Kirschbaum; D Hellhammer
Journal:  J Clin Chem Clin Biochem       Date:  1989-04

Review 7.  Salivary cortisol in psychoneuroendocrine research: recent developments and applications.

Authors:  C Kirschbaum; D H Hellhammer
Journal:  Psychoneuroendocrinology       Date:  1994       Impact factor: 4.905

8.  Differentiated sympathetic activation during mental stress evoked by the Stroop test.

Authors:  P Hjemdahl; U Freyschuss; A Juhlin-Dannfelt; B Linde
Journal:  Acta Physiol Scand Suppl       Date:  1984

Review 9.  Glucocorticoids may enhance oxygen radical-mediated neurotoxicity.

Authors:  L J McIntosh; R M Sapolsky
Journal:  Neurotoxicology       Date:  1996 Fall-Winter       Impact factor: 4.294

10.  Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement.

Authors:  R A Dressendörfer; C Kirschbaum; W Rohde; F Stahl; C J Strasburger
Journal:  J Steroid Biochem Mol Biol       Date:  1992-12       Impact factor: 4.292

View more
  11 in total

Review 1.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

2.  Diurnal patterns and associations among salivary cortisol, DHEA and alpha-amylase in older adults.

Authors:  Rand R Wilcox; Douglas A Granger; Sarah Szanton; Florence Clark
Journal:  Physiol Behav       Date:  2014-02-22

3.  Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone.

Authors:  Jonathan A Fidler; Christopher M Treleaven; Ashley Frakes; Thomas J Tamsett; Mary McCrate; Seng H Cheng; Lamya S Shihabuddin; Brian K Kaspar; James C Dodge
Journal:  FASEB J       Date:  2011-08-29       Impact factor: 5.191

4.  Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Eiichi Tokuda; Shunsuke Watanabe; Eriko Okawa; Shin-ichi Ono
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 5.  Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord.

Authors:  L Zubeldia-Brenner; C E Roselli; S E Recabarren; M C Gonzalez Deniselle; H E Lara
Journal:  J Neuroendocrinol       Date:  2016-07       Impact factor: 3.627

6.  Disease and Degeneration of Aging Neural Systems that Integrate Sleep Drive and Circadian Oscillations.

Authors:  Kristan G Singletary; Nirinjini Naidoo
Journal:  Front Neurol       Date:  2011-10-24       Impact factor: 4.003

7.  Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model.

Authors:  Kelby M Killoy; Mariana Pehar; Benjamin A Harlan; Marcelo R Vargas
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

Review 8.  Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction.

Authors:  Yves Lecarpentier; Victor Claes; Guillaume Duthoit; Jean-Louis Hébert
Journal:  Front Physiol       Date:  2014-11-04       Impact factor: 4.566

9.  Distinct activation of the sympathetic adreno-medullar system and hypothalamus pituitary adrenal axis following the caloric vestibular test in healthy subjects.

Authors:  Sebastian Cozma; Cristina Mihaela Ghiciuc; Lisandra Damian; Vittorio Pasquali; Angelo Saponaro; Elena Catalina Lupusoru; Francesca Romana Patacchioli; Lucia Corina Dima-Cozma
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

Review 10.  Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases.

Authors:  Alejandro F De Nicola; Maria Meyer; Rachida Guennoun; Michael Schumacher; Hazel Hunt; Joseph Belanoff; E Ronald de Kloet; Maria Claudia Gonzalez Deniselle
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.